Literature DB >> 33688812

Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting.

L Cates1, V Crudu2, A Codreanu3, N Ciobanu2, H Fosburgh4, T Cohen4, N A Menzies1.   

Abstract

Entities:  

Year:  2021        PMID： 33688812      PMCID： PMC7948759          DOI： 10.5588/ijtld.20.0586

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  8 in total

1.  Developing the Global Health Cost Consortium Unit Cost Study Repository for HIV and TB: methodology and lessons learned.

Authors:  Willyanne DeCormier Plosky; Lori A Bollinger; Lily Alexander; Drew B Cameron; Lauren N Carroll; Lucy Cunnama; Gabriela B Gomez; Carol Levin; Elliot Marseille; Mohamed Mustafa Diab; Mariana Siapka; Edina Sinanovic; Anna Vassall; James G Kahn
Journal:  Afr J AIDS Res       Date:  2019-12       Impact factor: 1.300

2.  Assessing tuberculosis control priorities in high-burden settings: a modelling approach.

Authors:  Juan F Vesga; Timothy B Hallett; Michael J A Reid; Kuldeep Singh Sachdeva; Raghuram Rao; Sunil Khaparde; Paresh Dave; Kiran Rade; Maureen Kamene; Eunice Omesa; Enos Masini; Newton Omale; Elizabeth Onyango; Philip Owiti; Muthoni Karanja; Richard Kiplimo; Sofia Alexandru; Valentina Vilc; Valeriu Crudu; Stela Bivol; Cristina Celan; Nimalan Arinaminpathy
Journal:  Lancet Glob Health       Date:  2019-03-20       Impact factor: 26.763

3.  Costs of patients hospitalized for multidrug-resistant tuberculosis.

Authors:  S S Rajbhandary; S M Marks; N N Bock
Journal:  Int J Tuberc Lung Dis       Date:  2004-08       Impact factor: 2.373

4.  Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively Drug-resistant Tuberculosis in the WHO European Region 2011-2015: Cost-effectiveness analysis.

Authors:  Zsuzsanna Jakab; Colleen D Acosta; Hans H Kluge; Masoud Dara
Journal:  Tuberculosis (Edinb)       Date:  2015-03-06       Impact factor: 3.131

Review 5.  Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.

Authors:  Yoko V Laurence; Ulla K Griffiths; Anna Vassall
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

6.  Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007.

Authors:  Suzanne M Marks; Jennifer Flood; Barbara Seaworth; Yael Hirsch-Moverman; Lori Armstrong; Sundari Mase; Katya Salcedo; Peter Oh; Edward A Graviss; Paul W Colson; Lisa Armitige; Manuel Revuelta; Kathryn Sheeran
Journal:  Emerg Infect Dis       Date:  2014-05       Impact factor: 6.883

7.  Cost analysis of rapid diagnostics for drug-resistant tuberculosis.

Authors:  Erik J Groessl; Theodore G Ganiats; Naomi Hillery; Andre Trollip; Roberta L Jackson; Donald G Catanzaro; Timothy C Rodwell; Richard S Garfein; Camilla Rodrigues; Valeriu Crudu; Thomas C Victor; Antonino Catanzaro
Journal:  BMC Infect Dis       Date:  2018-03-02       Impact factor: 3.090

8.  Reducing the price of treatment for multidrug-resistant tuberculosis through the Global Drug Facility.

Authors:  Kaspars Lunte; Thierry Cordier-Lassalle; Joel Keravec
Journal:  Bull World Health Organ       Date:  2015-02-27       Impact factor: 9.408
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.